康龙化成:拟20亿元建新药商业化生产和CDMO研发基地

财中社
May 27

  康龙化成(300759/03759)发布公告,公司于2026年5月27日与杭州市钱塘区招商服务中心签订投资协议,拟在杭州市钱塘区投资约20亿元新建新药商业化生产和CDMO研发生产服务基地。项目旨在提升公司新药商业化生产和研发服务的产能,进一步夯实核心业务。

  2026年一季度,康龙化成实现收入35.78亿元,归母净利润3.35亿元。

(文章来源:财中社)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10